NORTHERN TRUST CORP - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is and the CUSIP is 00444T209. A total of 36 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,348
-47.8%
10,944
-0.1%
0.00%
Q2 2023$12,166
+68.7%
10,9600.0%0.00%
Q1 2023$7,212
-70.9%
10,9600.0%0.00%
Q4 2022$24,76910,9600.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CANTOR FITZGERALD, L. P. 7,050$3,029,1030.08%
Nantahala Capital Management 1,173,015$680,3490.06%
Values First Advisors, Inc. 122,465$71,0300.05%
Nantahala Capital Management 755,000$437,9000.04%
TANG CAPITAL MANAGEMENT LLC 195,000$113,1000.02%
CANTOR FITZGERALD, L. P. 705,000$408,9000.01%
Rock Springs Capital Management LP 316,460$183,5470.01%
COWEN AND COMPANY, LLC 115,657$67,0810.01%
Virtu Financial LLC 25,641$150.00%
VANGUARD GROUP INC 171,791$99,6390.00%
View complete list of ACELRX PHARMACEUTICALS INC shareholders